Back Link
Reader View

Tarsus Pharmaceuticals CEO Bobak Azamian sells $803,100 in shares

www.investing.com · November 18, 2026 · 00:30
Paywall detected

This article has a paywall

The publisher blocks direct access to this article.

Open link